Oct 19, 2021 2:00am EDT NeoGenomics' Liquid Biopsy Subsidiary Inivata Announces Clinical Collaboration With Princess Margaret Cancer Center for the Use of Its Liquid Biopsy Assays
Oct 13, 2021 4:20pm EDT NeoGenomics Schedules its Third Quarter 2021, Earnings Release for November 4, 2021
Sep 09, 2021 7:00am EDT NeoGenomics' Liquid Biopsy Subsidiary Inivata and Collaborators to Present Data that Further Validate the Application of its RaDaR(TM) MRD and InVisionFirst(R)-Lung Assays at the ESMO Congress 2021
Sep 01, 2021 4:05pm EDT NeoGenomics to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference
